masavibart
2,667.00 ¥ 2,667.00 ¥ 2667.0 CNY
MCS110
2,667.00 ¥ 2,667.00 ¥ 2667.0 CNY
Mezagitamab (anti-CD38)
2,667.00 ¥ 2,667.00 ¥ 2667.0 CNY
Milatuzumab (anti-CD74)
2,667.00 ¥ 2,667.00 ¥ 2667.0 CNY
Mirikizumab (anti-IL-23)
2,667.00 ¥ 2,667.00 ¥ 2667.0 CNY
MM-111
2,667.00 ¥ 2,667.00 ¥ 2667.0 CNY
MM-151
2,667.00 ¥ 2,667.00 ¥ 2667.0 CNY
Mosunetuzumab (anti-CD20&CD3e)
139.00 ¥ 139.00 ¥ 139.0 CNY
Namilumab (anti-GM-CSF)
2,667.00 ¥ 2,667.00 ¥ 2667.0 CNY
Natalizumab (anti-ITGA4)
109.00 ¥ 109.00 ¥ 109.0 CNY
Nimotuzumab (anti-EGFR)
2,667.00 ¥ 2,667.00 ¥ 2667.0 CNY
Ocrelizumab (anti-CD20)
2,667.00 ¥ 2,667.00 ¥ 2667.0 CNY
Ontamalimab (anti-MADCAM1)
2,667.00 ¥ 2,667.00 ¥ 2667.0 CNY
Opicinumab (anti-LINGO1)
2,667.00 ¥ 2,667.00 ¥ 2667.0 CNY
OSE-127
2,667.00 ¥ 2,667.00 ¥ 2667.0 CNY
Osocimab (anti-Factor XI)
2,667.00 ¥ 2,667.00 ¥ 2667.0 CNY
Otilimab (anti-GM-CSF)
2,667.00 ¥ 2,667.00 ¥ 2667.0 CNY
Ozoralizumab (anti-TNF-alpha&HSA)
159.00 ¥ 159.00 ¥ 159.0 CNY
Pascolizumab (anti-IL-4)
2,667.00 ¥ 2,667.00 ¥ 2667.0 CNY
Pateclizumab (anti-TNFb)
2,667.00 ¥ 2,667.00 ¥ 2667.0 CNY